An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to Ofatumumab
Clinical trial NCT04353492 · COMPLETED
Trial details
- NCT number
- NCT04353492
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2024-10-09
- Enrollment
- 562
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.